In the first quarter of the fiscal year ending August 2026, net sales were 7,828 million yen (2.3% year-over-year increase), operating income was 2,255 million yen (7.0% increase), and net income attributable to owners of parent for the quarter was 1,896 million yen (18.6% increase).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7730","jir_company_name":"Manyo Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-01-14","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/01\/7730-20260114-01.pdf","jir_short_summary":"In the first quarter of the fiscal year ending August 2026, net sales were 7,828 million yen (2.3% year-over-year increase), operating income was 2,255 million yen (7.0% increase), and net income attributable to owners of parent for the quarter was 1,896 million yen (18.6% increase).","jir_summary":"### Overview of Business Results\nIn the first quarter of the fiscal year ending August 2026, net sales amounted to 7,828 million yen (2.3% year-over-year increase), operating income was 2,255 million yen (7.0% increase), ordinary income was 2,686 million yen (16.9% increase), and net income attributable to owners of parent for the quarter was 1,896 million yen (18.6% increase), achieving both higher revenues and profits. Key factors included increased sales of Aireless Needle-related products mainly in Asia, centered on China and Thailand; stable sales of surgical-related products in Europe and Japan; resumption of sales of diamond burs in China; and increased orders from major customers of the German subsidiary MMG. Selling, general and administrative expenses rose only 0.3% year-over-year, contributing to the increase in operating income.\n\n### Performance by Business Segment\nSales of surgical-related products were 2,446 million yen (0.2% year-over-year increase), with segment income of 827 million yen (1.4% decrease). While sales of ophthalmic knives remained stable in Europe and Japan, some inventory adjustments occurred due to medical cost policies in China. Aireless Needle-related products posted 3,006 million yen in sales (5.7% increase) and segment income of 1,106 million yen (5.8% increase), driven by large orders mainly from China and Thailand, achieving growth in both revenue and profit. Dental-related products recorded sales of 2,375 million yen (0.3% increase) and segment income of 322 million yen (44.7% increase), with profit recovering significantly mainly due to the restart of diamond bur sales in China and resolution of settlement bonus effects.\n\n### Overview of Financial Position\nTotal assets increased by 1,591 million yen from the previous consolidated fiscal year-end to 59,579 million yen, and net assets rose by 1,127 million yen to 54,689 million yen. The increase was mainly due to higher current assets, primarily cash and deposits. Liabilities increased by 463 million yen to 4,889 million yen. The equity ratio remained at a high level of 91.8%.\n\n### Outlook\nThe consolidated earnings forecast for the fiscal year ending August 2026 anticipates net sales of 32,800 million yen (9.4% year-over-year increase), operating income of 9,200 million yen (12.3% increase), ordinary income of 8,950 million yen (8.2% increase), and net income attributable to owners of parent of 6,450 million yen (38.9% increase). There are no revisions based on the first quarter results. The plan factors in recovery of diamond bur products in China and expansion in the European market.","jir_financial_highlights":"Net Sales: 7,828 million yen (2.3% year-over-year increase)\nOperating Income: 2,255 million yen (7.0% year-over-year increase)\nOrdinary Income: 2,686 million yen (16.9% year-over-year increase)\nNet Income Attributable to Owners of Parent: 1,896 million yen (18.6% year-over-year increase)\nTotal Assets: 59,579 million yen (1,591 million yen increase from previous consolidated fiscal year-end)\nNet Assets: 54,689 million yen (1,127 million yen increase from previous consolidated fiscal year-end)\nEquity Ratio: 91.8% (Slight decrease from 92.4% at previous consolidated fiscal year-end)\nNumber of Issued Shares (at Period-End): 107,003,277 shares (Unchanged from previous consolidated fiscal year-end)","jir_category":"","jir_hashtags":"#ManyoCoLtd, #financial_summary, #JapaneseStocks","jir_key_figures":"Net Sales: 7,828 million yen (2.3% year-over-year increase)\nOperating Income: 2,255 million yen (7.0% year-over-year increase)\nNet Income Attributable to Owners of Parent for the Quarter: 1,896 million yen (18.6% year-over-year increase)","jir_meta_title":"Manyo Co., Ltd. Q1 FY2026 Financial Summary: Net Sales of 7,828 Million Yen, Up 2.3% Year-on-Year","jir_meta_description":"Manyo Co., Ltd. Q1 FY2026 financial summary report. Achieved net sales of 7,828 million yen (2.3% year-over-year increase), operating income of 2,255 million yen (7.0% increase), and net income of 1,896 million yen (18.6% increase). Recovery in the Chinese market and increased orders in Europe contributed.","jir_og_title":"Manyo Co., Ltd. Announces Q1 FY2026 Financial Summary","jir_og_description":"Achieved higher revenues and profits in the first quarter of FY2026. Recovery in the Chinese and European markets boosted performance.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Net Sales Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Q1 FY2025\\\",\\\"Q1 FY2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[7655,7828],\\\"backgroundColor\\\":\\\"#4e79a7\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Operating Income Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Q1 FY2025\\\",\\\"Q1 FY2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[2107,2255],\\\"backgroundColor\\\":\\\"#f28e2b\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"net_profit_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Net Income Attributable to Owners of Parent Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Q1 FY2025\\\",\\\"Q1 FY2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Income\\\",\\\"data\\\":[1598,1896],\\\"backgroundColor\\\":\\\"#e15759\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Revenue Breakdown (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Surgical-related Products\\\",\\\"Aireless Needle-related Products\\\",\\\"Dental-related Products\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Q1 FY2025\\\",\\\"data\\\":[2442,2844,2368],\\\"backgroundColor\\\":\\\"#4e79a7\\\"},{\\\"label\\\":\\\"Q1 FY2026\\\",\\\"data\\\":[2446,3006,2375],\\\"backgroundColor\\\":\\\"#f28e2b\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_profit_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Income (Operating Income) Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Surgical-related Products\\\",\\\"Aireless Needle-related Products\\\",\\\"Dental-related Products\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Q1 FY2025\\\",\\\"data\\\":[838,1046,222],\\\"backgroundColor\\\":\\\"#4e79a7\\\"},{\\\"label\\\":\\\"Q1 FY2026\\\",\\\"data\\\":[827,1106,322],\\\"backgroundColor\\\":\\\"#f28e2b\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}]","ir_related_company":9190,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-19116","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n